Print

New Method Identifies Genes That Can Predict Prognoses of Cancer Patients, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute and IRCM Study  
1/28/2013 7:30:20 AM

In recent years, it has been thought that select sets of genes might reveal cancer patients' prognoses. However, a study published last year examining breast cancer cases found that most of these "prognostic signatures" were no more accurate than random gene sets in determining cancer prognoses. While many saw this as a disappointment, investigators at Beth Israel Deaconess Medical Center (BIDMC), the Dana-Farber Cancer Institute, and the Institut de Recherches Cliniques de Montréal (IRCM) saw this as an opportunity to design a new method to identify gene sets that could yield more significant prognostic value.
//-->